Morphoceuticals
Listen in to Prof Michael Levin & Prof David Kaplan discussing the Morphoceuticals vision and groundbreaking approach of mapping & manipulating the bioelectrome to induce regeneration.
The Longevity Forum
Bridging science and society to help achieve longer, healthier and more fulfilled lives for as many people as possible.
Accelerated hit identification with target evaluation, deep learning and automated labs: prospective validation in IRAK1
Abstract Background Target identification and hit identification can be transformed through the application of biomedical knowledge analysis, AI-driven virtual screening and robotic […]
Biomarkers of Aging Consortium
I had the best time attending the 2024 Biomarkers of Aging Consortium Conference at Harvard Medical School !
First day at the The Longevity Forum in London
A fantastic first day at the The Longevity Forum in London, filled with valuable insights.
SE(3) Equivariant Topologies for Structure-based Drug Discovery
Abstract Modeling protein-ligand interactions is a challenging task that has been approached through an array of perspectives. From physics-based computational approaches to […]
HydraScreen: A Generalizable Structure-Based Deep Learning Approach to Drug Discovery
We propose HydraScreen, a deep-learning framework for safe and robust accelerated drug discovery. HydraScreen utilizes a state-of-the-art 3D convolutional neural network designed […]
Juvenescence: Think aging up, rather than disease down
New CEO set to Marshall longevity with a pipeline that delivers immediate therapeutic benefit, but always has an eye on a future preventative angle.
Master Investor 2022: Our CEO, Dr. Greg Bailey, presents Juvenescence
The investment community is chasing a longer, healthier life like the rest of us.
The Simple Biotech Podcast: ‘Investing in the Longevity Industry: The Greatest Investment Opportunity in Human History’
What makes longevity one of the greatest investment opportunities in human history?
Juvenescence Chairman explains why investing in longevity has the potential to deliver significant financial, personal and humanitarian returns.
There’s a lot of great stuff happening, but it’s not one drug that’s going to keep you alive another 10 years in good health
THE BUCK INSTITUTE, WHERE THE PROMISE OF AGING RESEARCH ISN’T LONGEVITY
The leaders of the Buck Institute for Research on Aging want you to know that they’re not going to make you immortal.